img

Global Interventional Tumor Ablation Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Interventional Tumor Ablation Market Research Report 2024

Interventional tumor ablation is a minimally invasive medical procedure performed to treat certain types of tumors. It involves the use of various techniques to destroy or eliminate tumors without the need for open surgery. The goal of interventional tumor ablation is to selectively target and destroy tumor cells while minimizing damage to surrounding healthy tissues.
According to MRAResearch’s new survey, global Interventional Tumor Ablation market is projected to reach US$ 2940.8 million in 2033, increasing from US$ 1654.2 million in 2022, with the CAGR of 9.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Interventional Tumor Ablation market research.
There has been an increasing demand for minimally invasive treatment options for tumors. Interventional tumor ablation techniques, such as radiofrequency ablation, microwave ablation, cryoablation, and laser ablation, offer less invasive alternatives to traditional surgery. Patients often prefer these procedures due to their shorter recovery times, reduced complications, and the potential to preserve organ function.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Interventional Tumor Ablation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Boston Scientific Corporation
Johnson & Johnson
Medtronic Plc
Varian Medical Systems
EDAP TMS S.A.
AngioDynamics
CASCINATION AG
Merit Medical Systems
STARmed
Segment by Type
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation Ablation

Segment by Application


Hospitals And Clinics
Outpatient Surgery Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Interventional Tumor Ablation report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Interventional Tumor Ablation Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Radiofrequency Ablation
1.2.3 Microwave Ablation
1.2.4 Cryoablation
1.2.5 Irreversible Electroporation Ablation
1.3 Market by Application
1.3.1 Global Interventional Tumor Ablation Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals And Clinics
1.3.3 Outpatient Surgery Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Interventional Tumor Ablation Market Perspective (2018-2033)
2.2 Interventional Tumor Ablation Growth Trends by Region
2.2.1 Global Interventional Tumor Ablation Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Interventional Tumor Ablation Historic Market Size by Region (2018-2023)
2.2.3 Interventional Tumor Ablation Forecasted Market Size by Region (2024-2033)
2.3 Interventional Tumor Ablation Market Dynamics
2.3.1 Interventional Tumor Ablation Industry Trends
2.3.2 Interventional Tumor Ablation Market Drivers
2.3.3 Interventional Tumor Ablation Market Challenges
2.3.4 Interventional Tumor Ablation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Interventional Tumor Ablation Players by Revenue
3.1.1 Global Top Interventional Tumor Ablation Players by Revenue (2018-2023)
3.1.2 Global Interventional Tumor Ablation Revenue Market Share by Players (2018-2023)
3.2 Global Interventional Tumor Ablation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Interventional Tumor Ablation Revenue
3.4 Global Interventional Tumor Ablation Market Concentration Ratio
3.4.1 Global Interventional Tumor Ablation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Interventional Tumor Ablation Revenue in 2022
3.5 Interventional Tumor Ablation Key Players Head office and Area Served
3.6 Key Players Interventional Tumor Ablation Product Solution and Service
3.7 Date of Enter into Interventional Tumor Ablation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Interventional Tumor Ablation Breakdown Data by Type
4.1 Global Interventional Tumor Ablation Historic Market Size by Type (2018-2023)
4.2 Global Interventional Tumor Ablation Forecasted Market Size by Type (2024-2033)
5 Interventional Tumor Ablation Breakdown Data by Application
5.1 Global Interventional Tumor Ablation Historic Market Size by Application (2018-2023)
5.2 Global Interventional Tumor Ablation Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Interventional Tumor Ablation Market Size (2018-2033)
6.2 North America Interventional Tumor Ablation Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Interventional Tumor Ablation Market Size by Country (2018-2023)
6.4 North America Interventional Tumor Ablation Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Interventional Tumor Ablation Market Size (2018-2033)
7.2 Europe Interventional Tumor Ablation Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Interventional Tumor Ablation Market Size by Country (2018-2023)
7.4 Europe Interventional Tumor Ablation Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Interventional Tumor Ablation Market Size (2018-2033)
8.2 Asia-Pacific Interventional Tumor Ablation Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Interventional Tumor Ablation Market Size by Region (2018-2023)
8.4 Asia-Pacific Interventional Tumor Ablation Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Interventional Tumor Ablation Market Size (2018-2033)
9.2 Latin America Interventional Tumor Ablation Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Interventional Tumor Ablation Market Size by Country (2018-2023)
9.4 Latin America Interventional Tumor Ablation Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Interventional Tumor Ablation Market Size (2018-2033)
10.2 Middle East & Africa Interventional Tumor Ablation Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Interventional Tumor Ablation Market Size by Country (2018-2023)
10.4 Middle East & Africa Interventional Tumor Ablation Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boston Scientific Corporation
11.1.1 Boston Scientific Corporation Company Detail
11.1.2 Boston Scientific Corporation Business Overview
11.1.3 Boston Scientific Corporation Interventional Tumor Ablation Introduction
11.1.4 Boston Scientific Corporation Revenue in Interventional Tumor Ablation Business (2018-2023)
11.1.5 Boston Scientific Corporation Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Interventional Tumor Ablation Introduction
11.2.4 Johnson & Johnson Revenue in Interventional Tumor Ablation Business (2018-2023)
11.2.5 Johnson & Johnson Recent Development
11.3 Medtronic Plc
11.3.1 Medtronic Plc Company Detail
11.3.2 Medtronic Plc Business Overview
11.3.3 Medtronic Plc Interventional Tumor Ablation Introduction
11.3.4 Medtronic Plc Revenue in Interventional Tumor Ablation Business (2018-2023)
11.3.5 Medtronic Plc Recent Development
11.4 Varian Medical Systems
11.4.1 Varian Medical Systems Company Detail
11.4.2 Varian Medical Systems Business Overview
11.4.3 Varian Medical Systems Interventional Tumor Ablation Introduction
11.4.4 Varian Medical Systems Revenue in Interventional Tumor Ablation Business (2018-2023)
11.4.5 Varian Medical Systems Recent Development
11.5 EDAP TMS S.A.
11.5.1 EDAP TMS S.A. Company Detail
11.5.2 EDAP TMS S.A. Business Overview
11.5.3 EDAP TMS S.A. Interventional Tumor Ablation Introduction
11.5.4 EDAP TMS S.A. Revenue in Interventional Tumor Ablation Business (2018-2023)
11.5.5 EDAP TMS S.A. Recent Development
11.6 AngioDynamics
11.6.1 AngioDynamics Company Detail
11.6.2 AngioDynamics Business Overview
11.6.3 AngioDynamics Interventional Tumor Ablation Introduction
11.6.4 AngioDynamics Revenue in Interventional Tumor Ablation Business (2018-2023)
11.6.5 AngioDynamics Recent Development
11.7 CASCINATION AG
11.7.1 CASCINATION AG Company Detail
11.7.2 CASCINATION AG Business Overview
11.7.3 CASCINATION AG Interventional Tumor Ablation Introduction
11.7.4 CASCINATION AG Revenue in Interventional Tumor Ablation Business (2018-2023)
11.7.5 CASCINATION AG Recent Development
11.8 Merit Medical Systems
11.8.1 Merit Medical Systems Company Detail
11.8.2 Merit Medical Systems Business Overview
11.8.3 Merit Medical Systems Interventional Tumor Ablation Introduction
11.8.4 Merit Medical Systems Revenue in Interventional Tumor Ablation Business (2018-2023)
11.8.5 Merit Medical Systems Recent Development
11.9 STARmed
11.9.1 STARmed Company Detail
11.9.2 STARmed Business Overview
11.9.3 STARmed Interventional Tumor Ablation Introduction
11.9.4 STARmed Revenue in Interventional Tumor Ablation Business (2018-2023)
11.9.5 STARmed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Interventional Tumor Ablation Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Radiofrequency Ablation
Table 3. Key Players of Microwave Ablation
Table 4. Key Players of Cryoablation
Table 5. Key Players of Irreversible Electroporation Ablation
Table 6. Global Interventional Tumor Ablation Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Interventional Tumor Ablation Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Interventional Tumor Ablation Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Interventional Tumor Ablation Market Share by Region (2018-2023)
Table 10. Global Interventional Tumor Ablation Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Interventional Tumor Ablation Market Share by Region (2024-2033)
Table 12. Interventional Tumor Ablation Market Trends
Table 13. Interventional Tumor Ablation Market Drivers
Table 14. Interventional Tumor Ablation Market Challenges
Table 15. Interventional Tumor Ablation Market Restraints
Table 16. Global Interventional Tumor Ablation Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Interventional Tumor Ablation Market Share by Players (2018-2023)
Table 18. Global Top Interventional Tumor Ablation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Tumor Ablation as of 2022)
Table 19. Ranking of Global Top Interventional Tumor Ablation Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Interventional Tumor Ablation Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Interventional Tumor Ablation Product Solution and Service
Table 23. Date of Enter into Interventional Tumor Ablation Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Interventional Tumor Ablation Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Interventional Tumor Ablation Revenue Market Share by Type (2018-2023)
Table 27. Global Interventional Tumor Ablation Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Interventional Tumor Ablation Revenue Market Share by Type (2024-2033)
Table 29. Global Interventional Tumor Ablation Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Interventional Tumor Ablation Revenue Market Share by Application (2018-2023)
Table 31. Global Interventional Tumor Ablation Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Interventional Tumor Ablation Revenue Market Share by Application (2024-2033)
Table 33. North America Interventional Tumor Ablation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Interventional Tumor Ablation Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Interventional Tumor Ablation Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Interventional Tumor Ablation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Interventional Tumor Ablation Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Interventional Tumor Ablation Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Interventional Tumor Ablation Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Interventional Tumor Ablation Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Interventional Tumor Ablation Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Interventional Tumor Ablation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Interventional Tumor Ablation Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Interventional Tumor Ablation Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Interventional Tumor Ablation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Interventional Tumor Ablation Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Interventional Tumor Ablation Market Size by Country (2024-2033) & (US$ Million)
Table 48. Boston Scientific Corporation Company Detail
Table 49. Boston Scientific Corporation Business Overview
Table 50. Boston Scientific Corporation Interventional Tumor Ablation Product
Table 51. Boston Scientific Corporation Revenue in Interventional Tumor Ablation Business (2018-2023) & (US$ Million)
Table 52. Boston Scientific Corporation Recent Development
Table 53. Johnson & Johnson Company Detail
Table 54. Johnson & Johnson Business Overview
Table 55. Johnson & Johnson Interventional Tumor Ablation Product
Table 56. Johnson & Johnson Revenue in Interventional Tumor Ablation Business (2018-2023) & (US$ Million)
Table 57. Johnson & Johnson Recent Development
Table 58. Medtronic Plc Company Detail
Table 59. Medtronic Plc Business Overview
Table 60. Medtronic Plc Interventional Tumor Ablation Product
Table 61. Medtronic Plc Revenue in Interventional Tumor Ablation Business (2018-2023) & (US$ Million)
Table 62. Medtronic Plc Recent Development
Table 63. Varian Medical Systems Company Detail
Table 64. Varian Medical Systems Business Overview
Table 65. Varian Medical Systems Interventional Tumor Ablation Product
Table 66. Varian Medical Systems Revenue in Interventional Tumor Ablation Business (2018-2023) & (US$ Million)
Table 67. Varian Medical Systems Recent Development
Table 68. EDAP TMS S.A. Company Detail
Table 69. EDAP TMS S.A. Business Overview
Table 70. EDAP TMS S.A. Interventional Tumor Ablation Product
Table 71. EDAP TMS S.A. Revenue in Interventional Tumor Ablation Business (2018-2023) & (US$ Million)
Table 72. EDAP TMS S.A. Recent Development
Table 73. AngioDynamics Company Detail
Table 74. AngioDynamics Business Overview
Table 75. AngioDynamics Interventional Tumor Ablation Product
Table 76. AngioDynamics Revenue in Interventional Tumor Ablation Business (2018-2023) & (US$ Million)
Table 77. AngioDynamics Recent Development
Table 78. CASCINATION AG Company Detail
Table 79. CASCINATION AG Business Overview
Table 80. CASCINATION AG Interventional Tumor Ablation Product
Table 81. CASCINATION AG Revenue in Interventional Tumor Ablation Business (2018-2023) & (US$ Million)
Table 82. CASCINATION AG Recent Development
Table 83. Merit Medical Systems Company Detail
Table 84. Merit Medical Systems Business Overview
Table 85. Merit Medical Systems Interventional Tumor Ablation Product
Table 86. Merit Medical Systems Revenue in Interventional Tumor Ablation Business (2018-2023) & (US$ Million)
Table 87. Merit Medical Systems Recent Development
Table 88. STARmed Company Detail
Table 89. STARmed Business Overview
Table 90. STARmed Interventional Tumor Ablation Product
Table 91. STARmed Revenue in Interventional Tumor Ablation Business (2018-2023) & (US$ Million)
Table 92. STARmed Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Interventional Tumor Ablation Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Interventional Tumor Ablation Market Share by Type: 2022 VS 2033
Figure 3. Radiofrequency Ablation Features
Figure 4. Microwave Ablation Features
Figure 5. Cryoablation Features
Figure 6. Irreversible Electroporation Ablation Features
Figure 7. Global Interventional Tumor Ablation Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Interventional Tumor Ablation Market Share by Application: 2022 VS 2033
Figure 9. Hospitals And Clinics Case Studies
Figure 10. Outpatient Surgery Center Case Studies
Figure 11. Others Case Studies
Figure 12. Interventional Tumor Ablation Report Years Considered
Figure 13. Global Interventional Tumor Ablation Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Interventional Tumor Ablation Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Interventional Tumor Ablation Market Share by Region: 2022 VS 2033
Figure 16. Global Interventional Tumor Ablation Market Share by Players in 2022
Figure 17. Global Top Interventional Tumor Ablation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Tumor Ablation as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Interventional Tumor Ablation Revenue in 2022
Figure 19. North America Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Interventional Tumor Ablation Market Share by Country (2018-2033)
Figure 21. United States Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Interventional Tumor Ablation Market Share by Country (2018-2033)
Figure 25. Germany Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Interventional Tumor Ablation Market Share by Region (2018-2033)
Figure 33. China Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Interventional Tumor Ablation Market Share by Country (2018-2033)
Figure 41. Mexico Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Interventional Tumor Ablation Market Share by Country (2018-2033)
Figure 45. Turkey Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Interventional Tumor Ablation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Boston Scientific Corporation Revenue Growth Rate in Interventional Tumor Ablation Business (2018-2023)
Figure 48. Johnson & Johnson Revenue Growth Rate in Interventional Tumor Ablation Business (2018-2023)
Figure 49. Medtronic Plc Revenue Growth Rate in Interventional Tumor Ablation Business (2018-2023)
Figure 50. Varian Medical Systems Revenue Growth Rate in Interventional Tumor Ablation Business (2018-2023)
Figure 51. EDAP TMS S.A. Revenue Growth Rate in Interventional Tumor Ablation Business (2018-2023)
Figure 52. AngioDynamics Revenue Growth Rate in Interventional Tumor Ablation Business (2018-2023)
Figure 53. CASCINATION AG Revenue Growth Rate in Interventional Tumor Ablation Business (2018-2023)
Figure 54. Merit Medical Systems Revenue Growth Rate in Interventional Tumor Ablation Business (2018-2023)
Figure 55. STARmed Revenue Growth Rate in Interventional Tumor Ablation Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed